BioTime (BTX) and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents Portal Offering Additional PureStem Human Progenitor Cells Including Those for Diabetes Research
5/7/2013 10:48:09 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (http://bioreagents.lifemapsc.com/) featuring an improved user interface, product descriptions, and customer support options, as well as the addition of new PureStem™ progenitor cells to the site. These novel progenitors provide new and unique tools for researchers to study developmental biology, tissue genesis and regenerative medicine, demonstrating purity in culture and unique gene expression. Among the new product offerings are novel PureStem™ progenitor cells such as the E72 cells capable of differentiating into betatrophin-expressing adipocytes, which may be useful in diabetes research.
Help employers find you! Check out all the jobs and post your resume.